Michael Yee
Stock Analyst at UBS
(3.41)
# 2,349
Out of 5,023 analysts
1344
Total ratings
47.3%
Success rate
2.3%
Average return
Main Sectors:
Stocks Rated by Michael Yee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PFE Pfizer | Reiterated: Hold | $27 | $27.80 | -2.88% | 9 | Oct 2, 2026 | |
| IVA Inventiva | Reiterated: Buy | $12 | $3.56 | +237.08% | 4 | Sep 30, 2026 | |
| KOD Kodiak Sciences | Reiterated: Buy | $80 → $120 | $94.45 | +27.05% | 16 | Sep 28, 2026 | |
| VRTX Vertex Pharmaceuticals | Rated: Buy | $585 → $615 | $504.73 | +21.85% | 130 | Sep 28, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $175 | $144.74 | +20.91% | 189 | Sep 24, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $175 | $144.30 | +21.28% | 7 | Sep 24, 2026 | |
| ANAB AnaptysBio | Rated: Buy | $76 | $48.53 | +56.60% | 6 | Sep 22, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $320 | $256.03 | +24.99% | 3 | Sep 21, 2026 | |
| AMGN Amgen | Rated: Buy | $440 → $430 | $403.04 | +6.69% | 188 | Sep 17, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $60 | $46.81 | +28.18% | 16 | Sep 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $30.49 | +80.39% | 1 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $84.52 | +53.81% | 8 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 → $265 | $206.64 | +28.24% | 8 | Aug 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $61.15 | +30.83% | 6 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $150 | $190.01 | -21.06% | 71 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 | $33.28 | +95.31% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $34 | $20.00 | +70.00% | 18 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,425 | $1,142.85 | +24.69% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 → $240 | $219.88 | +9.15% | 172 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $90 | $58.51 | +53.82% | 6 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $230 → $260 | $262.82 | -1.07% | 6 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $14.12 | +218.70% | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $37.36 | +33.83% | 3 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $8.23 | +447.11% | 22 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $31.02 | +93.42% | 4 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.22 | +391.80% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $18 → $13 | $30.31 | -57.11% | 18 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $20 | $5.54 | +261.01% | 5 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $7 | $5.14 | +36.19% | 10 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.98 | +134.90% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $20.65 | +117.92% | 1 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $50 | $19.40 | +157.73% | 2 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $35 | $24.33 | +43.86% | 19 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.50 | +433.33% | 4 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $30 → $28 | $24.50 | +14.29% | 5 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $55 | $29.71 | +85.12% | 13 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $3.5 | $4.07 | n/a | 8 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $6 | $8.36 | n/a | 48 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $18 | $14.22 | n/a | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $8 | $2.32 | n/a | 6 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $1 | $12.33 | n/a | 34 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $58.39 | n/a | 2 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $46 → $10 | $0.8221 | n/a | 4 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $15 | $6.31 | n/a | 19 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $7 | $22.54 | n/a | 8 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $31 | $150,000.00 | n/a | 3 | Dec 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $1.77 | n/a | 3 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $1.13 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $4.63 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $1.43 | n/a | 2 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.0002 | n/a | 2 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $57.18 | n/a | 59 | Sep 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $19.95 | n/a | 2 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $8.36 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $47.15 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 | $541.70 | n/a | 43 | Feb 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $626 | $735.20 | n/a | 43 | Jan 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $57 | $9.51 | n/a | 9 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.54 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $113 | $115.30 | n/a | 9 | Nov 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $97.50 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $42.60 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $86.38 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $275.43 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $159.87 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $2 | $0.000001 | n/a | 5 | Jun 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $17.50 | n/a | 2 | Feb 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $193 | $386.43 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $371.90 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $2.96 | n/a | 2 | Jan 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $20 | $4.45 | n/a | 8 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $64.19 | n/a | 4 | Aug 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 | $4.54 | n/a | 4 | Jun 30, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $142.30 | n/a | 1 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $0.0008 | n/a | 2 | Mar 20, 2012 |
Pfizer
Oct 2, 2026
Reiterated: Hold
Price Target: $27
Current: $27.80
Upside: -2.88%
Inventiva
Sep 30, 2026
Reiterated: Buy
Price Target: $12
Current: $3.56
Upside: +237.08%
Kodiak Sciences
Sep 28, 2026
Reiterated: Buy
Price Target: $80 → $120
Current: $94.45
Upside: +27.05%
Vertex Pharmaceuticals
Sep 28, 2026
Rated: Buy
Price Target: $585 → $615
Current: $504.73
Upside: +21.85%
Gilead Sciences
Sep 24, 2026
Reiterated: Buy
Price Target: $175
Current: $144.74
Upside: +20.91%
Merck & Co.
Sep 24, 2026
Reiterated: Buy
Price Target: $175
Current: $144.30
Upside: +21.28%
AnaptysBio
Sep 22, 2026
Rated: Buy
Price Target: $76
Current: $48.53
Upside: +56.60%
Johnson & Johnson
Sep 21, 2026
Reiterated: Buy
Price Target: $320
Current: $256.03
Upside: +24.99%
Amgen
Sep 17, 2026
Rated: Buy
Price Target: $440 → $430
Current: $403.04
Upside: +6.69%
Scholar Rock Holding
Sep 13, 2026
Reiterated: Buy
Price Target: $60
Current: $46.81
Upside: +28.18%
Sep 11, 2026
Initiated Coverage: Buy
Price Target: $55
Current: $30.49
Upside: +80.39%
Sep 1, 2026
Reiterated: Buy
Price Target: $130
Current: $84.52
Upside: +53.81%
Aug 28, 2026
Reiterated: Buy
Price Target: $220 → $265
Current: $206.64
Upside: +28.24%
Aug 20, 2026
Reiterated: Buy
Price Target: $80
Current: $61.15
Upside: +30.83%
Aug 20, 2026
Reiterated: Hold
Price Target: $45 → $150
Current: $190.01
Upside: -21.06%
Aug 13, 2026
Rated: Buy
Price Target: $65
Current: $33.28
Upside: +95.31%
Aug 7, 2026
Rated: Buy
Price Target: $25 → $34
Current: $20.00
Upside: +70.00%
Aug 5, 2026
Reiterated: Buy
Price Target: $1,425
Current: $1,142.85
Upside: +24.69%
Jul 30, 2026
Reiterated: Buy
Price Target: $225 → $240
Current: $219.88
Upside: +9.15%
Jul 24, 2026
Reiterated: Buy
Price Target: $60 → $90
Current: $58.51
Upside: +53.82%
Jul 13, 2026
Rated: Hold
Price Target: $230 → $260
Current: $262.82
Upside: -1.07%
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $14.12
Upside: +218.70%
Jun 9, 2026
Reiterated: Buy
Price Target: $50
Current: $37.36
Upside: +33.83%
Jun 2, 2026
Reiterated: Buy
Price Target: $45
Current: $8.23
Upside: +447.11%
May 31, 2026
Reiterated: Buy
Price Target: $60
Current: $31.02
Upside: +93.42%
May 12, 2026
Reiterated: Buy
Price Target: $6
Current: $1.22
Upside: +391.80%
Mar 17, 2026
Rated: Hold
Price Target: $18 → $13
Current: $30.31
Upside: -57.11%
Mar 5, 2026
Reiterated: Buy
Price Target: $3 → $20
Current: $5.54
Upside: +261.01%
Mar 3, 2026
Reiterated: Hold
Price Target: $10 → $7
Current: $5.14
Upside: +36.19%
Feb 25, 2026
Reiterated: Buy
Price Target: $7
Current: $2.98
Upside: +134.90%
Feb 17, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $20.65
Upside: +117.92%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $45 → $50
Current: $19.40
Upside: +157.73%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $50 → $35
Current: $24.33
Upside: +43.86%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.50
Upside: +433.33%
Jan 6, 2026
Initiated Coverage: Hold
Price Target: $30 → $28
Current: $24.50
Upside: +14.29%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $45 → $55
Current: $29.71
Upside: +85.12%
Jun 25, 2025
Reiterated: Hold
Price Target: $1.5 → $3.5
Current: $4.07
Upside: n/a
May 27, 2025
Downgraded: Hold
Price Target: $32 → $6
Current: $8.36
Upside: n/a
Mar 13, 2025
Reiterated: Buy
Price Target: $24 → $18
Current: $14.22
Upside: n/a
Mar 6, 2025
Reiterated: Buy
Price Target: $145 → $8
Current: $2.32
Upside: n/a
Oct 25, 2023
Downgraded: Hold
Price Target: $3 → $1
Current: $12.33
Upside: n/a
Mar 22, 2023
Reiterated: Buy
Price Target: $26
Current: $58.39
Upside: n/a
Dec 22, 2021
Downgraded: Hold
Price Target: $46 → $10
Current: $0.8221
Upside: n/a
Aug 10, 2021
Reiterated: Hold
Price Target: $45 → $15
Current: $6.31
Upside: n/a
Dec 21, 2020
Reiterated: Hold
Price Target: $10 → $7
Current: $22.54
Upside: n/a
Dec 21, 2018
Reiterated: Buy
Price Target: $40 → $31
Current: $150,000.00
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $1.5 → $1
Current: $1.77
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $3.5
Current: $1.13
Upside: n/a
Jul 8, 2018
Reiterated: Buy
Price Target: $22
Current: $4.63
Upside: n/a
Oct 27, 2017
Reiterated: Buy
Price Target: $47
Current: $1.43
Upside: n/a
Oct 2, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.0002
Upside: n/a
Sep 25, 2017
Reiterated: Buy
Price Target: $116
Current: $57.18
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $47
Current: $19.95
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $7
Current: $8.36
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $5
Current: $47.15
Upside: n/a
Feb 23, 2017
Reiterated: Hold
Price Target: $110
Current: $541.70
Upside: n/a
Jan 3, 2017
Reiterated: Buy
Price Target: $626
Current: $735.20
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: $57
Current: $9.51
Upside: n/a
Dec 20, 2016
Reiterated: Buy
Price Target: $25
Current: $1.54
Upside: n/a
Nov 14, 2016
Reiterated: Buy
Price Target: $113
Current: $115.30
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $48
Current: $97.50
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $28
Current: $42.60
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $95
Current: $86.38
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $129
Current: $275.43
Upside: n/a
Jul 28, 2016
Reiterated: Buy
Price Target: $115
Current: $159.87
Upside: n/a
Jun 15, 2016
Downgraded: Hold
Price Target: $12 → $2
Current: $0.000001
Upside: n/a
Feb 5, 2016
Reiterated: Hold
Price Target: $15
Current: $17.50
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $193
Current: $386.43
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $157
Current: $371.90
Upside: n/a
Jan 4, 2016
Reiterated: Hold
Price Target: $7
Current: $2.96
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $35 → $20
Current: $4.45
Upside: n/a
Aug 5, 2015
Reiterated: Hold
Price Target: $9
Current: $64.19
Upside: n/a
Jun 30, 2014
Rated: Hold
Price Target: $40
Current: $4.54
Upside: n/a
Jun 29, 2012
Upgraded: Buy
Price Target: n/a
Current: $142.30
Upside: n/a
Mar 20, 2012
Reiterated: Buy
Price Target: $28
Current: $0.0008
Upside: n/a